High-performance liquid chromatographic method for the determination of labetalol in plasma using ultraviolet detection (Q71301113)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6707148%20AND%20SRC:MED&resulttype=core&format=json

17 October 2019

title

High-performance liquid chromatographic method for the determination of labetalol in plasma using ultraviolet detection (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6707148%20AND%20SRC:MED&resulttype=core&format=json

17 October 2019

author name string

I J Hidalgo

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6707148%20AND%20SRC:MED&resulttype=core&format=json

17 October 2019

K T Muir

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6707148%20AND%20SRC:MED&resulttype=core&format=json

17 October 2019

publication date

1 January 1984

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6707148%20AND%20SRC:MED&resulttype=core&format=json

17 October 2019

volume

305

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6707148%20AND%20SRC:MED&resulttype=core&format=json

17 October 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6707148%20AND%20SRC:MED&resulttype=core&format=json

17 October 2019

page(s)

222-227

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6707148%20AND%20SRC:MED&resulttype=core&format=json

Preliminary studies of the pharmacological effects of 5-[1-hydroxy-2-((1-methyl-3-phenylpropyl)amino)-ethyl] salicylamide (AH 5158) in man

17 October 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2983334-4

7 January 2021

Pharmacology of AH 5158; a drug which blocks both - and -adrenoceptors

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2983334-4

7 January 2021

Assessment of alpha- and beta-adrenoceptor blocking actions of labetalol

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2983334-4

7 January 2021

Letter: Intravenous labetalol in severe hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2983334-4

7 January 2021

Relationship between plasma concentrations and pharmacological effects of labetalol

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2983334-4

7 January 2021

Pharmacokinetics and pharmacodynamic studies of labetalol in hypertensive subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2983334-4

7 January 2021

The determination of labetalol in plasma by high-performance liquid chromatography using fluorescence detection

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2983334-4

7 January 2021

Sensitive high-performance liquid chromatographic method for the determination of labetalol in human plasma using fluorimetric detection

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2983334-4

7 January 2021

Determination of labetalol in human plasma by high-performance liquid chromatography

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2983334-4

7 January 2021

Labetalol: bioavailability, drug plasma levels, plasma renin and catecholamines in acute and chronic treatment of resistant hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2983334-4

7 January 2021

10.1016/S0378-4347(00)83334-4

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6707148%20AND%20SRC:MED&resulttype=core&format=json

17 October 2019

1 reference